This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Decentralized Clinical Trials
Hybrid Event | June 6 - 8, 2022
In-Person Event: June 6 - 8, Hyatt Regency Coral Gables, Miami, FloridaDigital Experience: Live-streamed keynotes on June 6 - 8 + 10 days on-demand access to all presentation recordings from June 14th

Science 37 Holdings, Inc.

Profile

Science 37 Holdings, Inc. (Nasdaq: SNCE) mission is to enable universal access to clinical research—making it easier for patients and providers to participate from anywhere and helping to accelerate the development of treatments that impact patient lives. As a pioneer of decentralized clinical trials, the Science 37 Clinical Trial Operating System (OS) supports today’s more agile clinical research designs with its full stack, end-to-end technology platform and specialized networks of patient communities, telemedicine investigators, mobile nurses, remote coordinators and connected devices. Configurable to enable any study type, the Science 37 OS enables up to 15x faster enrollment, 28% better retention and 3x more diverse patient population with industry-leading workflow orchestration, evidence generation and data harmonization. For more information, visit https://www.science37.com.

We're bringing you

  • What’s Next in Clinical Research—Technology that Delivers the Agile Trial

    4:30pm